Aimovig is an injectable medication used to prevent migraine episodes. Unopened doses should be stored in the refrigerator in the original packaging away from light, and they can be used until the ...

TRENTON, N.J. -- U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration's action clears the monthly shot Aimovig for sale. It's the ...

Aimovig is a brand-name prescription medication known as a biologic. Its active ingredient is erenumab-aooe. Generic versions of biologic medications are called biosimilars. Due to complex ...

THOUSAND OAKS, Calif., Oct. 3, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that results reinforcing the long-term safety and efficacy profile of Aimovig® (erenumab-aooe) in patients with ...

Migraine sufferers across the United States have their eyes on a newly approved drug that’s offering hope for reducing the frequency of monthly migraine attacks. On Thursday, the US Food and Drug ...

England's cost watchdogs admit that migraine sufferers have a shortage of options and must deal with waiting lines for Allergan's Botox—and that in some parts of the country, it isn't even available.

It happened! After yearning for the new “miracle” migraine drug, I was finally approved for monthly injections. So, that’s the good news. The bad news is that ...

There is finally a light at the end of the tunnel for people who suffer from chronic or episodic migraine headaches. It's called Aimovig, and as a lifelong migraineur, the news that migraine sufferers ...

Please provide your email address to receive an email when new articles are posted on . Aimovig appeared safe and effective for treating migraine with and without history of aura, according to results ...

LOS ANGELES (Reuters) - A late-stage trial of Amgen Inc's experimental drug Aimovig found that it reduced episodic migraines by at least half in 30 percent of patients who had failed up to four ...

The FDA has approved a new migraine drug that can cut the number of attacks patients suffer each month. The drug, called erenumab-aooe and marketed as Aimovig, is the first preventative migraine ...

Migraine sufferers across the United States have their eyes on a newly approved drug that’s offering hope for reducing the frequency of monthly migraine attacks. On Thursday, the US Food and Drug ...